公司简介
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar refe...
关联新闻
- Biogen's anti-tau Alzheimer's drug benefits increase at 2 years
Biogen's anti-tau Alzheimer's drug benefits increase at 2 years
- Biogen Swings to Loss, Logs Higher Sales
The biotechnology company said the swing to a loss was primarily due to transaction-related charges.
- Biogen's experimental lupus drug shows benefit against skin symptoms
Biogen said on Friday its experimental drug showed durable improvement in skin symptoms among patients with a type of autoimmune disease in a mid-stage study.